Surgical safety of immediate versus deferred cytoreductive nephrectomy (CN) in patients with synchronous metastatic renal cell carcinoma (mRCC) receiving sunitinib. Data from the EORTC randomized trial 30073 SURTIME
Bex, A., Mulders, P., Jewett, M., Wagstaff, J., Van Velthoven, R., Laguna, P., Wood, L., Van Melick, H., Soetekouw, P., Lattouf, J., Powles, T., De Jong, I., Rottey, S., Tombal, B., Marreaud, S., CollVolume:
17
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(18)30856-X
Date:
March, 2018
File:
PDF, 210 KB
english, 2018